The document discusses calcium channel blockers (CCBs), which are a class of antihypertensive drugs. CCBs work by blocking calcium channels, thereby relaxing blood vessels and reducing blood pressure. They are classified into phenylalkylamines, dihydropyridines, and benzothiazepines. CCBs are effective antihypertensives and are also used to treat angina by dilating coronary arteries and reducing oxygen demand of the heart. Their adverse effects include headaches, dizziness, and hypotension. CCBs are contraindicated in conditions like heart failure and bradycardia.